|
. Less a minute
The DEFUSE 3 Trial and the DAWN trial, released in 2017, provide overwhelming evidence that treating patients up to 24 hours after ischemic stroke can be safe and effective. The results of these trials resulted in rapid guideline updates by the American Heart Association and the American Stroke Association. Click on the link below for details about the new guidelines.
Read original article...Internal Medicine board review videos let you study every topic for exams at your own pace. Plus, they're a great way to...
Are you taking an ABP exam this year? Or maybe you just need a good review for practice? Then our Pediatrics Review Cour...
